GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:00328721 | Colorectum | MSS | regulation of stress-activated MAPK cascade | 51/3467 | 192/18723 | 3.65e-03 | 2.69e-02 | 51 |
GO:00435422 | Colorectum | MSS | endothelial cell migration | 70/3467 | 279/18723 | 3.69e-03 | 2.71e-02 | 70 |
GO:00100382 | Colorectum | MSS | response to metal ion | 90/3467 | 373/18723 | 3.76e-03 | 2.76e-02 | 90 |
GO:00071781 | Colorectum | MSS | transmembrane receptor protein serine/threonine kinase signaling pathway | 86/3467 | 355/18723 | 4.04e-03 | 2.95e-02 | 86 |
GO:0048659 | Colorectum | MSS | smooth muscle cell proliferation | 49/3467 | 184/18723 | 4.08e-03 | 2.97e-02 | 49 |
GO:0048660 | Colorectum | MSS | regulation of smooth muscle cell proliferation | 48/3467 | 180/18723 | 4.32e-03 | 3.07e-02 | 48 |
GO:00346052 | Colorectum | MSS | cellular response to heat | 22/3467 | 69/18723 | 5.31e-03 | 3.62e-02 | 22 |
GO:0031929 | Colorectum | MSS | TOR signaling | 35/3467 | 126/18723 | 6.91e-03 | 4.44e-02 | 35 |
GO:0050678 | Colorectum | MSS | regulation of epithelial cell proliferation | 90/3467 | 381/18723 | 6.92e-03 | 4.45e-02 | 90 |
GO:0048762 | Colorectum | MSS | mesenchymal cell differentiation | 59/3467 | 236/18723 | 7.79e-03 | 4.84e-02 | 59 |
GO:00065131 | Colorectum | MSS | protein monoubiquitination | 21/3467 | 67/18723 | 7.90e-03 | 4.84e-02 | 21 |
GO:00328731 | Colorectum | MSS | negative regulation of stress-activated MAPK cascade | 17/3467 | 51/18723 | 8.28e-03 | 4.99e-02 | 17 |
GO:00703031 | Colorectum | MSS | negative regulation of stress-activated protein kinase signaling cascade | 17/3467 | 51/18723 | 8.28e-03 | 4.99e-02 | 17 |
GO:19033203 | Colorectum | MSI-H | regulation of protein modification by small protein conjugation or removal | 43/1319 | 242/18723 | 1.60e-08 | 1.85e-06 | 43 |
GO:00313963 | Colorectum | MSI-H | regulation of protein ubiquitination | 39/1319 | 210/18723 | 2.12e-08 | 2.36e-06 | 39 |
GO:00525473 | Colorectum | MSI-H | regulation of peptidase activity | 66/1319 | 461/18723 | 2.63e-08 | 2.81e-06 | 66 |
GO:00525483 | Colorectum | MSI-H | regulation of endopeptidase activity | 60/1319 | 432/18723 | 3.29e-07 | 2.57e-05 | 60 |
GO:20001163 | Colorectum | MSI-H | regulation of cysteine-type endopeptidase activity | 36/1319 | 235/18723 | 8.40e-06 | 4.09e-04 | 36 |
GO:00458623 | Colorectum | MSI-H | positive regulation of proteolysis | 49/1319 | 372/18723 | 1.67e-05 | 7.15e-04 | 49 |
GO:00432813 | Colorectum | MSI-H | regulation of cysteine-type endopeptidase activity involved in apoptotic process | 31/1319 | 209/18723 | 6.50e-05 | 2.19e-03 | 31 |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
DCD | SNV | Missense_Mutation | | c.151N>A | p.Leu51Ile | p.L51I | P81605 | protein_coding | tolerated_low_confidence(0.18) | possibly_damaging(0.87) | TCGA-D8-A1XM-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
DCD | SNV | Missense_Mutation | novel | c.298N>C | p.Glu100Gln | p.E100Q | P81605 | protein_coding | deleterious_low_confidence(0) | benign(0.322) | TCGA-4J-AA1J-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Unknown | Unknown | SD |
DCD | SNV | Missense_Mutation | | c.10A>G | p.Met4Val | p.M4V | P81605 | protein_coding | deleterious_low_confidence(0) | benign(0.075) | TCGA-AA-A02R-01 | Colorectum | colon adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | PD |
DCD | SNV | Missense_Mutation | novel | c.125A>C | p.Lys42Thr | p.K42T | P81605 | protein_coding | tolerated_low_confidence(0.1) | benign(0.017) | TCGA-AX-A3FT-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
DCD | SNV | Missense_Mutation | | c.71N>T | p.Ala24Val | p.A24V | P81605 | protein_coding | tolerated_low_confidence(0.47) | possibly_damaging(0.905) | TCGA-B5-A11E-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
DCD | SNV | Missense_Mutation | rs190416576 | c.265N>A | p.Glu89Lys | p.E89K | P81605 | protein_coding | deleterious_low_confidence(0.05) | benign(0.006) | TCGA-D1-A17Q-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
DCD | SNV | Missense_Mutation | | c.73N>T | p.Ala25Ser | p.A25S | P81605 | protein_coding | tolerated_low_confidence(0.17) | probably_damaging(0.998) | TCGA-FV-A2QQ-01 | Liver | liver hepatocellular carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
DCD | SNV | Missense_Mutation | | c.97C>A | p.Pro33Thr | p.P33T | P81605 | protein_coding | tolerated_low_confidence(0.52) | benign(0.231) | TCGA-MI-A75G-01 | Liver | liver hepatocellular carcinoma | Male | <65 | I/II | Unknown | Unknown | SD |
DCD | SNV | Missense_Mutation | | c.149G>A | p.Gly50Glu | p.G50E | P81605 | protein_coding | tolerated_low_confidence(0.49) | benign(0.367) | TCGA-55-1595-01 | Lung | lung adenocarcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
DCD | SNV | Missense_Mutation | | c.230N>C | p.Val77Ala | p.V77A | P81605 | protein_coding | deleterious_low_confidence(0.02) | benign(0) | TCGA-55-A4DF-01 | Lung | lung adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | PD |